Cocaine Use Disorder Clinical Trial
Official title:
Clinical Study of Imagery-based Coping for Cocaine Use Disorder
A pragmatic, 4-week, 4-group, between-subjects, factorial randomised controlled trial conducted at a specialist NHS outpatient addictions clinic and hospital clinical research facility to determine if mental imagery (of past and future positive [recovery oriented] and negative [cocaine aversive] events) can help reduce cue-induced cocaine craving and cocaine use.
Cocaine, a powerful stimulant drug, is used by 2.2% of people aged 16-59 in England and each
year about 150.000 people seek help for cocaine use disorder from the NHS or non-governmental
organisations (NGO). There are currently no approved medication-assisted treatments or
specific psychosocial interventions for CUD. General counselling is offered by the NHS and
NGO addiction services, but this is not particularly effective.
The transition from regular cocaine use to cocaine abuse is often marked by intense episodes
(binges), which may last several days and are followed by a 'crash' with no or little use.
For many people, repeated administration of cocaine over a short duration of time creates
vivid episodic memories of euphoria which can inform future craving content. Craving or
strong urges are a distinctive feature of CUD and are often reported as involuntary,
distressing and uncontrollable.
Research has demonstrated that craving experiences can be voluntarily evoked or elicited by
conditioned drug cues in the environment and internal processes such mood or physical
sensations. The associations between cues and use are established through classical and
instrumental reward-based conditioning and are important for the development and maintenance
of CUD. Enhanced attention to cocaine cues develops and remains heightened for at least six
months into abstinence.
Craving-related experiences are informed by memories of intense reward, physical sensations
and include pro-drug beliefs, appraisals, expectancies and vivid mental imagery. Drug-imagery
is often initially pleasurable and affectively charged and can motivate drug-seeking
behaviour. If impeded or delayed, drug imagery highlights a deficit and can be experienced as
distressing and intrusive. Treatment of intrusive images has been successful in various
psychological disorders using imagery rescripting. Imagery rescripting has recently been used
in memory-focused cognitive therapy to help reduce cocaine craving. Reducing intrusive
image-induced negative affect through positive imagery is important for relieving
psychological distress but there is also evidence that aversive imagery may reduce
maladaptive approach behaviours.
This will be a pragmatic, 4-week, 2x2, between-subjects, factorial randomised controlled
trial. It will be conducted at a specialist NHS outpatient addictions clinic (Lorraine Hewitt
House; LHH) operated by South London and Maudsley NHS Foundation trust (SLaM) and at the NIHR
Wellcome Trust King's Clinical Research Facility (CRF) at King's College Hospital.
Informed consenting adult participants will be randomised to one of four conditions:
- future-based (prospective) recovery-oriented imagery;
- future-based (prospective) cocaine-aversive imagery;
- past (autobiographical) recovery-oriented imagery; or
- past (autobiographical) cocaine-aversive imagery.
Participants will undergo a craving induction procedure designed to elicit cue-induced
craving. In response to elevated craving, participants will be asked to reduce their craving
levels using a mental imagery intervention.
Following the procedure in the research facility, participants will be given a digital audio
player to take home. This will contain a recording of the imagery condition they are
allocated to. Participants will be asked to listen to this recording each day during a 14-day
follow-up, and ad libertatem when experiencing cocaine craving. After 14 days participants
will be invited for a follow up conducted at the community addictions clinic.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03538548 -
Treatment Outcome in CBT for Cocaine Use
|
N/A | |
Recruiting |
NCT04994821 -
tDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study
|
Phase 2 | |
Not yet recruiting |
NCT06050304 -
CRACK-TARGET 1: ÉTUDE DESCRIPTIVE DE LA SENSIBILISATION COMPORTEMENTALE OBSERVÉE et ATTENTES
|
||
Completed |
NCT02239913 -
Topiramate-Phentermine Combinations for Cocaine Dependence
|
Phase 1 | |
Completed |
NCT02233647 -
Phendimetrazine and Cocaine
|
Early Phase 1 | |
Not yet recruiting |
NCT05974202 -
rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder
|
Phase 2 | |
Recruiting |
NCT04927143 -
Encouraging Abstinence Behavior in a Drug Epidemic
|
Phase 2 | |
Completed |
NCT03224546 -
Cocaine Use Reduction and Health
|
N/A | |
Completed |
NCT03348384 -
[11C]NOP-1A and Cocaine Use Disorders
|
Early Phase 1 | |
Recruiting |
NCT05019430 -
Cocaine and Zolmitriptan
|
Early Phase 1 | |
Recruiting |
NCT03344419 -
Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders
|
Phase 3 | |
Recruiting |
NCT05507814 -
Temporal Window and Episodic Future Thinking in CUD
|
N/A | |
Active, not recruiting |
NCT03799341 -
Neurocognitive Factors in Substance Use Treatment Response: The Ways of Rewarding Abstinence Project
|
N/A | |
Completed |
NCT02798627 -
Trial Of NS2359 For The Treatment of Cocaine Dependence
|
Phase 2 | |
Completed |
NCT02785406 -
Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use
|
Phase 2 | |
Completed |
NCT02444208 -
A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use
|
N/A | |
Recruiting |
NCT05902819 -
Reconsolidation Blockade of Intrusive Trauma- and Cocaine-related Memories
|
N/A | |
Recruiting |
NCT05833529 -
Innovative Cognitive and Behavioral Psychotherapy for Cocaine Use Disorder
|
N/A | |
Recruiting |
NCT05521854 -
Contingency Management for Drug Use: Does Age Matter?
|
N/A | |
Completed |
NCT05557149 -
Virtual Reality Exposure and Respiratory Relaxation-Based Coping With Cocaine Craving in Cocaine Users
|
N/A |